You are here

Interview with Richard Gralla

Recorded at TAO (Transatlantic Oncology meeting), November 20-21, 2014, Paris

interview Richard Gralla

Richard Gralla gives an update on the developments regarding new MASCC / ESMO guidelines for the prevention of cancer treatment related nausea and vomiting. He anticipates a lot of significant and interesting changes in the guidelines. Gralla, who chaired a session on anti PD-1 and anti PD-L1 drugs, also explains the mode of action of this interesting new class of drugs, and sees potential in now having three major ways to attack cancer cells: chemotherapy, genetic mutations and rearrangements, and the new therapies using the immune checkpoint.

Richard Gralla, A. Einstein School of Medicine, NY

Search this site

Featured videos

Free access to ebooks on cachexia and CINV


Prevention of nausea and vomiting in
adult cancer patients receiving tumour-
directed therapy – 2017 update –

Cancer cachexia: mechanisms and progress in treatment


Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo